S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
Log in

Cooper Companies Stock Price, Forecast & Analysis (NYSE:COO)

$301.98
+2.38 (+0.79 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
$297.50
Now: $301.98
$302.21
50-Day Range
$280.97
MA: $291.47
$299.49
52-Week Range
$228.65
Now: $301.98
$344.32
Volume184,749 shs
Average Volume243,360 shs
Market Capitalization$14.97 billion
P/E Ratio26.26
Dividend Yield0.02%
Beta0.9
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. Read More…

Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
CUSIP21664840
Phone925-460-3600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.53 billion
Cash Flow$17.67 per share
Book Value$67.31 per share

Profitability

Net Income$139.90 million

Miscellaneous

Employees12,000
Market Cap$14.97 billion
Next Earnings Date12/5/2019 (Confirmed)
OptionableOptionable

Receive COO News and Ratings via Email

Sign-up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.


Cooper Companies (NYSE:COO) Frequently Asked Questions

What is Cooper Companies' stock symbol?

Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?

Cooper Companies announced a Semi-Annual dividend on Wednesday, July 10th. Shareholders of record on Tuesday, July 23rd will be paid a dividend of $0.03 per share on Wednesday, August 7th. The ex-dividend date of this dividend is Monday, July 22nd. View Cooper Companies' Dividend History.

How were Cooper Companies' earnings last quarter?

Cooper Companies Inc (NYSE:COO) released its quarterly earnings data on Thursday, August, 29th. The medical device company reported $3.23 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $3.16 by $0.07. The medical device company had revenue of $679.40 million for the quarter, compared to analyst estimates of $687.60 million. Cooper Companies had a return on equity of 17.15% and a net margin of 17.08%. Cooper Companies's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period last year, the company posted $3.00 EPS. View Cooper Companies' Earnings History.

When is Cooper Companies' next earnings date?

Cooper Companies is scheduled to release their next quarterly earnings announcement on Thursday, December 5th 2019. View Earnings Estimates for Cooper Companies.

How can I listen to Cooper Companies' earnings call?

Cooper Companies will be holding an earnings conference call on Thursday, December 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Cooper Companies issued on next quarter's earnings?

Cooper Companies updated its FY19 earnings guidance on Thursday, August, 29th. The company provided EPS guidance of $12.27-12.35 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.28. The company issued revenue guidance of $2.635-2.655 billion, compared to the consensus revenue estimate of $2.65 billion.

What price target have analysts set for COO?

11 Wall Street analysts have issued 12 month target prices for Cooper Companies' stock. Their forecasts range from $221.00 to $365.00. On average, they expect Cooper Companies' stock price to reach $325.00 in the next year. This suggests a possible upside of 7.6% from the stock's current price. View Analyst Price Targets for Cooper Companies.

What is the consensus analysts' recommendation for Cooper Companies?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 1 sell rating, 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cooper Companies.

Has Cooper Companies been receiving favorable news coverage?

Media headlines about COO stock have been trending somewhat negative recently, InfoTrie reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cooper Companies earned a daily sentiment score of -1.4 on InfoTrie's scale. They also assigned news stories about the medical device company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Cooper Companies.

Are investors shorting Cooper Companies?

Cooper Companies saw a drop in short interest in the month of October. As of October 31st, there was short interest totalling 945,600 shares, a drop of 7.3% from the September 30th total of 1,020,000 shares. Based on an average trading volume of 307,800 shares, the short-interest ratio is presently 3.1 days. Approximately 1.9% of the shares of the stock are sold short. View Cooper Companies' Current Options Chain.

Who are some of Cooper Companies' key competitors?

What other stocks do shareholders of Cooper Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cooper Companies investors own include Netflix (NFLX), NVIDIA (NVDA), Starbucks (SBUX), Booking (BKNG), Baidu (BIDU), Boeing (BA), Intuitive Surgical (ISRG), Alibaba Group (BABA), Mastercard (MA) and Adobe (ADBE).

Who are Cooper Companies' key executives?

Cooper Companies' management team includes the folowing people:
  • Mr. Albert G. White III, Pres, CEO & Director (Age 49)
  • Mr. Brian G. Andrews, Sr. VP, CFO & Treasurer (Age 40)
  • Mr. Daniel G. McBride, Exec. VP & COO (Age 55)
  • Ms. Holly R. Sheffield, Exec. VP & Chief Strategy Officer (Age 48)
  • Dr. Robert D. Auerbach, Pres of Coopersurgical Inc (Age 58)

Who are Cooper Companies' major shareholders?

Cooper Companies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (4.01%), Veritas Asset Management LLP (2.00%), California Public Employees Retirement System (0.80%), WCM Investment Management LLC (0.75%), Findlay Park Partners LLP (0.67%) and Handelsbanken Fonder AB (0.62%). Company insiders that own Cooper Companies stock include A Thomas Bender, Agostino Ricupati, Allan E Rubenstein, Brian G Andrews, Carol R Kaufman, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg. View Institutional Ownership Trends for Cooper Companies.

Which institutional investors are selling Cooper Companies stock?

COO stock was sold by a variety of institutional investors in the last quarter, including Findlay Park Partners LLP, Massachusetts Financial Services Co. MA, Public Employees Retirement Association of Colorado, Sawgrass Asset Management LLC, BB&T Securities LLC, Fisher Asset Management LLC, Mackay Shields LLC and Congress Asset Management Co. MA. Company insiders that have sold Cooper Companies company stock in the last year include Agostino Ricupati, Allan E Rubenstein, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Jody S Lindell, Michael Kalkstein, Randal Golden, Robert D Auerbach, Robert S Weiss and Stanley Md Zinberg. View Insider Buying and Selling for Cooper Companies.

Which institutional investors are buying Cooper Companies stock?

COO stock was bought by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., California Public Employees Retirement System, State of Alaska Department of Revenue, WCM Investment Management LLC, State of Tennessee Treasury Department, Russell Investments Group Ltd., Veritas Asset Management LLP and James Hambro & Partners. View Insider Buying and Selling for Cooper Companies.

How do I buy shares of Cooper Companies?

Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cooper Companies' stock price today?

One share of COO stock can currently be purchased for approximately $301.98.

How big of a company is Cooper Companies?

Cooper Companies has a market capitalization of $14.97 billion and generates $2.53 billion in revenue each year. The medical device company earns $139.90 million in net income (profit) each year or $11.50 on an earnings per share basis. Cooper Companies employs 12,000 workers across the globe.View Additional Information About Cooper Companies.

What is Cooper Companies' official website?

The official website for Cooper Companies is http://www.coopercos.com/.

How can I contact Cooper Companies?

Cooper Companies' mailing address is 6140 Stoneridge Mall Road Suite 590, PLEASANTON CA, 94588. The medical device company can be reached via phone at 925-460-3600 or via email at [email protected]


MarketBeat Community Rating for Cooper Companies (NYSE COO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  505 (Vote Outperform)
Underperform Votes:  439 (Vote Underperform)
Total Votes:  944
MarketBeat's community ratings are surveys of what our community members think about Cooper Companies and other stocks. Vote "Outperform" if you believe COO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel